Published in Biomed Res Int on May 11, 2014
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem (1982) 27.26
A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther (1959) 16.61
The L-arginine-nitric oxide pathway. N Engl J Med (1993) 14.38
Anaphylaxis to the Separated Proteins of Horse-serum. Biochem J (1916) 12.27
Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med (2002) 6.52
Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest (2005) 5.53
A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Methods (1980) 4.76
Inducible nitric oxide synthase: what difference does it make? J Clin Invest (1997) 3.72
Kounis syndrome: a new twist on an old disease. Future Cardiol (2011) 2.51
Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med (2000) 2.46
Eosinophils generate brominating oxidants in allergen-induced asthma. J Clin Invest (2000) 2.05
Oxidative stress in allergic respiratory diseases. J Allergy Clin Immunol (2002) 1.90
Identification and characterization of a novel monoamine transporter in the human brain. J Biol Chem (2004) 1.88
Interaction of organic cations with a newly identified plasma membrane monoamine transporter. Mol Pharmacol (2005) 1.63
The mechanism of histamine secretion from gastric enterochromaffin-like cells. Am J Physiol (1999) 1.60
Enhanced superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis (1992) 1.57
The heart as a target organ in systemic allergic reactions: comparison of cardiac analphylaxis in vivo and in vitro. Circ Res (1975) 1.55
Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling. Circ Res (2003) 1.55
Selective substrates for non-neuronal monoamine transporters. Mol Pharmacol (1999) 1.47
Sensitivity of the response of cytosolic calcium in Quin-2-loaded rat hepatocytes to glucagon, adenine nucleosides, and adenine nucleotides. J Biol Chem (1985) 1.42
Cellular and molecular aspects of drug transport in the kidney. Kidney Int (2000) 1.41
Genomics meets histamine receptors: new subtypes, new receptors. Mol Pharmacol (2001) 1.41
Our perception of the mast cell from Paul Ehrlich to now. Eur J Immunol (2009) 1.39
Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice. Mol Cell Biol (2001) 1.37
Cytoprotective function of nitric oxide: inactivation of superoxide radicals produced by human leukocytes. Biochem Biophys Res Commun (1991) 1.29
Cloning and characterization of a novel human histamine receptor. J Pharmacol Exp Ther (2001) 1.26
Histamine and cardiac arrhythmias. Circ Res (1986) 1.23
Unidirectional uptake of substrates at the blood side of secretory epithelia: stomach, salivary gland, pancreas. Fed Proc (1982) 1.23
Differentiation of the roles of histamine H1- and H2-receptors in the mediation of the effects of histamine in the isolated working heart of the guinea-pig. Br J Pharmacol (1979) 1.17
Nitric oxide and cardioprotection during ischemia-reperfusion. Heart Fail Rev (2002) 1.16
Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression. Am J Physiol Endocrinol Metab (2000) 1.10
Pharmacological characterization of cardiac histamine receptors: sensitivity to H1-receptor antagonists. Eur J Pharmacol (1974) 1.06
Glucagon stimulates the cardiac Ca2+ current by activation of adenylyl cyclase and inhibition of phosphodiesterase. Nature (1990) 1.06
Alterations in intracellular reactive oxygen species generation and redox potential modulate mast cell function. Eur J Immunol (1997) 1.02
Separation of primary and secondary cardiovascular events in systemic anaphylaxis. Circ Res (1977) 0.99
Microvascular oxygenation, oxidative stress, NO suppression and superoxide dismutase during postischemic reperfusion. Am J Physiol Heart Circ Physiol (2003) 0.98
Histamine upregulates gene expression of endothelial nitric oxide synthase in human vascular endothelial cells. Circulation (2003) 0.98
Vesicular monoamine transporter 2 (VMAT2) expression in hematopoietic cells and in patients with systemic mastocytosis. J Histochem Cytochem (2005) 0.97
Mast cells in vulnerable atherosclerotic plaques--a view to a kill. J Cell Mol Med (2007) 0.96
Resident cardiac mast cells and ischemia-reperfusion injury. J Cardiovasc Pharmacol Ther (2003) 0.93
Recent advances in molecular pharmacology of the histamine systems: organic cation transporters as a histamine transporter and histamine metabolism. J Pharmacol Sci (2006) 0.92
Glucagon increases contractility in ventricle but not in atrium of the rat heart. Eur J Pharmacol (2008) 0.90
A review of potential cardiovascular uses of intravenous glucagon administration. J Clin Pharmacol (1999) 0.89
Immunologic and nonimmunologic generation of superoxide from mast cells and basophils. J Clin Invest (1978) 0.88
Novel effects of histamine on lipoprotein metabolism: suppression of hepatic low density lipoprotein receptor expression and reduction of plasma high density lipoprotein cholesterol in the rat. Endocrinology (1997) 0.86
Involvement of nitric oxide in cardioprotective effect of endothelin receptor antagonist during ischemia-reperfusion. Am J Physiol Heart Circ Physiol (2001) 0.84
Ischemia/reperfusion-induced death of cardiac myocytes: possible involvement of nitric oxide in the coordination of ATP supply and demand during ischemia. J Mol Cell Cardiol (2005) 0.84
Reduction of ventricular fibrillation threshold by histamine: resolution into separate H1- and H2-mediated components. J Pharmacol Exp Ther (1982) 0.84
Research progress on neurobiology of neuronal nitric oxide synthase. Neurosci Bull (2011) 0.83
Heterogenous effects of histamine on isolated rat coronary arteries. Eur J Pharmacol (1994) 0.82
Protective effect of relaxin in cardiac anaphylaxis: involvement of the nitric oxide pathway. Br J Pharmacol (2002) 0.82
Chronotropic and dromotropic effects of histamine on the canine heart. Chest (1979) 0.81
Effect of glucagon on amitriptyline-induced cardiovascular toxicity in rats. Hum Exp Toxicol (2008) 0.81
Glucose release as a response to glucagon in rat hepatocyte culture: involvement of NO signaling. Physiol Res (2007) 0.81
Nitric oxide modulates cardiac and mast cell anaphylaxis. Agents Actions (1994) 0.80
Uptake of histamine by mouse peritoneal macrophages and a macrophage cell line, RAW264.7. Am J Physiol Cell Physiol (2003) 0.80
Role of L-arginine in preventing myocardial and endothelial injury following ischaemia/reperfusion in the rat isolated heart. Acta Physiol Scand (1996) 0.80
Glucagon effects on ischemic vasodilatation in the isolated rat heart. J Biomed Biotechnol (2010) 0.80
Possible role of nitric oxide and mast cells in endotoxin-induced cardioprotection. Pharmacol Res (2001) 0.79
Ventricular arrhythmias parallel cardiac histamine efflux after coronary artery occlusion in the dog. Agents Actions (1988) 0.79
Protective effects of glucagon during the anaphylactic response in guinea-pig isolated heart. Br J Pharmacol (1982) 0.78
Expression of inducible nitric oxide synthase in a mouse model of anaphylaxis. J Investig Allergol Clin Immunol (2007) 0.78
Biphasic L-arginine uptake by the isolated guinea-pig heart. Exp Physiol (1995) 0.76
Kinetics of thyroxine (T(4)) and triiodothyronine (T(3)) transport in the isolated rat heart. Exp Physiol (2001) 0.76